Interferon alpha-2 FDA Link

Alpha interferon encoded by the human IFNA2 gene. Recombinant forms are used in the treatment of CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; KAPOSI SARCOMA; MELANOMA; and HAIRY CELL LEUKEMIA.

Also Known As:

Roferon-A; IFN-alpha 2; IFN-alpha-2; IFNalpha-2b, Recombinant; Interferon alfa-2a; Interferon alfa-2b; Interferon alpha-2b, Recombinant; Interferon alpha-A; Interferon-alpha 2; Intron A (Interferon); LeIF A; Reaferon; Recombinant Interferon alpha-2a; Recombinant Interferon alpha-2b; Ro 22-8181; Sch-30500; Viferon; IFNalpha 2b, Recombinant; Interferon alfa 2a; Interferon alfa 2b; Interferon alpha 2; Interferon alpha 2b, Recombinant; Interferon alpha A; Interferon alpha-2a, Recombinant; Recombinant IFNalpha-2b; Recombinant Interferon alpha 2a; Recombinant Interferon alpha 2b; Ro 22 8181; Ro 228181; Roferon A; RoferonA; Sch 30500; Sch30500

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Intercellular Signaling Peptides and Proteins: 29768
    - Cytokines: 164289
      - Interferons: 39171
        Interferon Type I: 4788
        Interferon-alpha: 11740
        Interferon alpha-2: 1506
- Peptides: 82426
  - Intercellular Signaling Peptides and Proteins: 29768
    - Cytokines: 164289
      - Interferons: 39171
        Interferon Type I: 4788
        Interferon-alpha: 11740
        Interferon alpha-2: 1506
Biological Factors: 2472
- Intercellular Signaling Peptides and Proteins: 29768
  - Cytokines: 164289
    - Interferons: 39171
      - Interferon Type I: 4788
        Interferon-alpha: 11740
        Interferon alpha-2: 1506

Miriam Tanja Zincke Selected Research

Miriam Tanja Zincke Research Topics

Disease

Drug/Important Bio-Agent (IBA)